✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹843 Cr.
P/E
16.77
About
Anuh Pharma Ltd is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) and a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceuti… Read more
Anuh Pharma Ltd is one of the leading manufacturers of Active Pharmaceutical Ingredients (API… Read more
Low
148
52W Range
High
258
  • Anuh Pharma
  • Wanbury
  • Shivalik Rasayan
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

9 Yes

Positive for this company

3 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
22 %
(as of Mar 22)
Chloramphenicol - Market Share
7 %
(as of Mar 22)
Corticosteroids - Market Share
18 %
(as of Mar 22)
Erythromycin - Market Share
2 %
(as of Mar 22)
Higher Macrolides(Azithromycin)
33 %
(as of Mar 22)
Pyrazinamide - Market Share
12.50 %
(as of Mar 22)
Sulfaxoxine
Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Brand Wise Break-Up

Operational Metrics

    Select a Metric
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Anuh Pharma Ltd. Business

    Anuh Pharma Ltd is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and also deals in bulk drugs, chemicals, and pharmaceutical formulations.

    Anuh Pharma major competitors are Wanbury, Shivalik Rasayan, Kwality Pharma, Bharat Parenterals, Kilitch Drugs(India), Sakar Healthcare, Medicamen Biotech.
    Market Cap of Anuh Pharma is ₹843 Crs.
    While the median market cap of its peers are ₹681 Crs.

    Anuh Pharma seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation Sep Mar Jun Dec Feb Mar May Jun Aug Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Jun Sep Dec Sep Dec
    Conference Call Mar Jun Sep Dec Dec
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material